Presentation TCT 2015 New Randomized Trial Data (2-Year Outcomes): ABSORB II (TCT First Report Investigation Results and Beyond) Presenter: Bernard R. Chevalier October 14, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status Presenter: Roxana Mehran October 14, 2015 More slides + Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015 Presentation TCT 2015 Acroredis, Iris Fit, and CARAG ASD Occluder Presenter: Horst Sievert October 14, 2015 We Recommend
Presentation TCT 2015 The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status Presenter: Roxana Mehran October 14, 2015
Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015
Presentation TCT 2015 Acroredis, Iris Fit, and CARAG ASD Occluder Presenter: Horst Sievert October 14, 2015